Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 13, 2017High and durable response rate in disease without any FDA-approved therapies
-
Dec 11, 2017* First FDA-approved follow-on mealtime insulin
-
Dec 7, 2017Phase 3 trials will evaluate isatuximab, an anti-CD38 antibody, in combination with other cancer treatments
-
Dec 4, 2017First head-to-head randomized clinical trial comparing the efficacy and safety of Toujeo (insulin glargine 300 Units/mL) versus insulin degludec
-
Nov 30, 2017Two large real-world analyses compared adults with type 2 diabetes who were switched to Toujeo (insulin glargine injection 300 Units/mL) to those switched to insulin degludec
-
Oct 31, 2017First study with a biologic to show benefit in severe steroid-dependent asthma population that enrolled patients regardless of blood eosinophil levels or any other Type 2 biomarkers at baseline